Related Experiment Video
Updated: Jul 3, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Obesity and sexual dysfunction in younger Danish men
Ingelise Andersen1, Berit L Heitmann, Berit L Heitman
1Copenhagen University, Institute of Public Health Science-Social Medicine, Copenhagen, Denmark. inan@pubhealth.ku.dk
The Journal of Sexual Medicine
|July 16, 2008
Summary
Obesity is linked to a nearly threefold increased risk of erectile dysfunction (ED) in younger men aged 20-45. Other sexual disorders were not associated with obesity in this study group.
Area of Science:
- Men's Health
- Sexual Health
- Obesity Research
Background:
- Rising global obesity rates impact over 50% of adult Western men.
- Understanding the link between obesity and sexual function is crucial.
Purpose of the Study:
- To investigate the association between obesity and sexual disorders (erectile dysfunction, ejaculatory disorders, sexual desire disorders) in younger Danish men.
- To analyze these associations across different age groups and smoking statuses.
Main Methods:
- Community-based cross-sectional study involving 863 Danish men aged 20-45.
- Anonymous questionnaires assessed self-reported sexual health and body mass index (BMI).
- Logistic regression modeling calculated odds ratios.
Main Results:
- Obesity (BMI ≥ 30 kg/m²) was significantly associated with erectile dysfunction (ED) in younger men (OR 2.74).
- ED prevalence was higher in younger obese non-smokers compared to obese smokers.
- No significant association was found between obesity and ejaculatory or sexual desire disorders.
Conclusions:
- Obesity is a significant risk factor for erectile dysfunction in men aged 20-45.
- Public health initiatives promoting healthy weight in young men may reduce ED incidence.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...